{
  "id": 208739,
  "name": "NEUROCRINE BIOSCIENCES, INC.",
  "slug": "neurocrine-biosciences-inc",
  "state": "CA",
  "description": "Science focused biopharma company focused on neuro, endo and psych disorders",
  "totalSpending": 1410000,
  "filings": 18,
  "yearlySpending": [
    {
      "year": 2021,
      "income": 290000
    },
    {
      "year": 2022,
      "income": 320000
    },
    {
      "year": 2023,
      "income": 320000
    },
    {
      "year": 2024,
      "income": 240000
    },
    {
      "year": 2025,
      "income": 240000
    }
  ],
  "firms": [
    "TARPLIN, DOWNS & YOUNG, LLC"
  ],
  "lobbyists": [
    "RAISSA DOWNS",
    "JENNIFER YOUNG",
    "MICHELLE EASTON",
    "ELIZABETH MURRAY",
    "CHARLOTTE IVANCIC",
    "PAMELA SMITH",
    "EMILY MURRY",
    "KIMBERLY BRANDT",
    "MARGARET JOSEPH",
    "PETER FISE",
    "LAURA FRIEDEL",
    "PARICK CARROLL"
  ],
  "issues": [
    "HCR",
    "MMM",
    "BUD",
    null
  ],
  "sampleDescriptions": [
    "Telehealth, CMS coverage and reimbursement, user fee reauthorizations",
    "S. Con.  Res. 5 (117)",
    "H.R. 1319, American Rescue Plan of 2021 \nprescription drug pricing\npayment reform\ninnovation",
    "H.R. 1319, American Rescue Plan of 2021 implementation\nprescription drug pricing\npayment reform\ninnovation",
    "S. Con.  Res. 5 (117)\nreconciliation",
    "reconciliation\nS. Con. Res. 14",
    "prescription drug pricing\npayment reform\ninnovation\nH.R. 1319, American Rescue Plan of 2021 implementation\nH.R. 3, The Lower Drug Costs Now Act",
    "prescription drug pricing\npayment reform\ninnovation\nH.R. 1319, American Rescue Plan of 2021 implementation\nH.R. 5376, the Build Back Better Act",
    "H.R. 2471, Consolidated Appropriations Act 2022 reconciliation",
    "H.R. 5376, the Build Back Better Act prescription drug pricing, payment reform, innovation",
    "H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023",
    "H.R. 5376, the Inflation Reduction Act prescription drug pricing, payment reform, innovation",
    "H.R.2617 - Consolidated Appropriations Act, 2023",
    "H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, payment reform, innovation",
    "IRA implementation, prescription drug pricing, payment reform, innovation",
    "telehealth, mental health",
    "IRA, prescription drug pricing, payment reform, innovation",
    "telehealth, mental health, prescription drug pricing, payment reform",
    "federal budget issues"
  ],
  "years": [
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": -17,
  "trajectory": "stable",
  "yearsActive": 5,
  "avgAnnualSpending": 282000,
  "peakYear": 2022,
  "lobbyistCount": 12,
  "firmCount": 1,
  "issueCount": 3
}